FDA approves first OTC HIV test

FDA approved OraQuick In-Home HIV Test from OraSure Technologies Inc. (NASDAQ:OSUR) to detect antibodies to HIV-1 and HIV-2 from an oral swab. OraSure said it will launch the test in October and will set pricing closer to launch. The test is an OTC version of OraSure's OraQuick Advance Rapid HIV-1/2 point-of-care test. ...